Bristlecone Advisors, LLC Dexcom Inc Transaction History

Bristlecone Advisors, LLC

  • $1.24 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024
SELL
$75.49 - $124.16 $11,474 - $18,872
-152 Reduced 6.46%
2,200 $272,000
Q3 2023

Oct 16, 2023
SELL
$86.06 - $137.93 $4,130 - $6,620
-48 Reduced 2.0%
2,352 $219,000
Q2 2023

Aug 03, 2023
BUY
$112.47 - $130.98 $5,398 - $6,287
48 Added 2.04%
2,400 $308,000
Q4 2022

Feb 14, 2023
BUY
$84.98 - $122.67 $199,872 - $288,519
2,352 New
2,352 $266,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bristlecone Advisors, LLC Portfolio

Follow Bristlecone Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email